1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Parkinson’s disease medication state and severity assessment based on coordination during walking

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Walking is a complex motor function requiring coordination of all body parts. Parkinson’s disease (PD) motor signs such as rigidity, bradykinesia, and impaired balance affect movements including walking. Here, we propose a computational method to objectively assess the effects of Parkinson’s disease pathology on coordination between trunk, shoulder and limbs during the gait cycle to assess medication state and disease severity. Movements during a scripted walking task were extracted from wearable devices placed at six different body locations in participants with PD and healthy participants. Three-axis accelerometer data from each device was synchronized at the beginning of either left or right steps. Canonical templates of movements were then extracted from each body location. Movements projected on those templates created a reduced dimensionality space, where complex movements are represented as discrete values. These projections enabled us to relate the body coordination in people with PD to disease severity. Our results show that the velocity profile of the right wrist and right foot during right steps correlated with the participant’s total score on the gold standard Unified Parkinson’s Disease Rating Scale (UPRDS) with an r 2 up to 0.46. Left-right symmetry of feet, trunk and wrists also correlated with the total UPDRS score with an r 2 up to 0.3. In addition, we demonstrate that binary dopamine replacement therapy medication states (self-reported ‘ON’ or ‘OFF’) can be discriminated in PD participants. In conclusion, we showed that during walking, the movement of body parts individually and in coordination with one another changes in predictable ways that vary with disease severity and medication state.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

          We present a clinimetric assessment of the Movement Disorder Society (MDS)-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UDPRS Task Force revised and expanded the UPDRS using recommendations from a published critique. The MDS-UPDRS has four parts, namely, I: Non-motor Experiences of Daily Living; II: Motor Experiences of Daily Living; III: Motor Examination; IV: Motor Complications. Twenty questions are completed by the patient/caregiver. Item-specific instructions and an appendix of complementary additional scales are provided. Movement disorder specialists and study coordinators administered the UPDRS (55 items) and MDS-UPDRS (65 items) to 877 English speaking (78% non-Latino Caucasian) patients with Parkinson's disease from 39 sites. We compared the two scales using correlative techniques and factor analysis. The MDS-UPDRS showed high internal consistency (Cronbach's alpha = 0.79-0.93 across parts) and correlated with the original UPDRS (rho = 0.96). MDS-UPDRS across-part correlations ranged from 0.22 to 0.66. Reliable factor structures for each part were obtained (comparative fit index > 0.90 for each part), which support the use of sum scores for each part in preference to a total score of all parts. The combined clinimetric results of this study support the validity of the MDS-UPDRS for rating PD.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Parkinsonism: onset, progression, and mortality

            M Hoehn, M Yahr (1967)
            Neurology, 17(5), 427-427
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Gait impairments in Parkinson's disease

              Gait impairments are among the most common and disabling symptoms of Parkinson's disease. Nonetheless, gait is not routinely assessed quantitatively but is described in general terms that are not sensitive to changes ensuing with disease progression. Quantifying multiple gait features (eg, speed, variability, and asymmetry) under natural and more challenging conditions (eg, dual-tasking, turning, and daily living) enhanced sensitivity of gait quantification. Studies of neural connectivity and structural network topology have provided information on the mechanisms of gait impairment. Advances in the understanding of the multifactorial origins of gait changes in patients with Parkinson's disease promoted the development of new intervention strategies, such as neurostimulation and virtual reality, aimed at alleviating gait impairments and enhancing functional mobility. For clinical applicability, it is important to establish clear links between specific gait impairments, their underlying mechanisms, and disease progression to foster the acceptance and usability of quantitative gait measures as outcomes in future disease-modifying clinical trials.
                Bookmark

                Author and article information

                Contributors
                Role: Formal analysisRole: ValidationRole: Writing – original draft
                Role: Data curationRole: ValidationRole: Writing – original draft
                Role: Data curation
                Role: Data curationRole: Investigation
                Role: ConceptualizationRole: InvestigationRole: SoftwareRole: SupervisionRole: VisualizationRole: Writing – original draft
                Role: Editor
                Journal
                PLoS One
                PLoS One
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, CA USA )
                1932-6203
                17 February 2021
                2021
                : 16
                : 2
                : e0244842
                Affiliations
                [1 ] IBM Research - Healthcare and Life Sciences, Yorktown Heights, Yorktown, New York, United States of America
                [2 ] Department of Neurology, Boston, Massachusetts, United States of America
                Istituto Italiano di Tecnologia, ITALY
                Author notes

                Competing Interests: C. Agurto, S. Heisig, A. Abrami, V. Caggiano, disclose that their employer, IBM Research, is the research branch of IBM Corporation. B.K. Ho is employed by the Department of Neurology, Tufts University School of Medicine and Tufts Medical Center. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

                [¤a]

                Current address: Department of Neurology at Icahn School of Medicine at Mount Sinai, New York, New York, United States of America

                [¤b]

                Current address: Facebook AI Research, New York, New York, United States of America

                Author information
                https://orcid.org/0000-0002-2186-1550
                Article
                PONE-D-20-15516
                10.1371/journal.pone.0244842
                7888646
                33596202
                96e8167f-08a1-41a0-8517-7c5637b5813d
                © 2021 Agurto et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 25 May 2020
                : 18 December 2020
                Page count
                Figures: 4, Tables: 3, Pages: 15
                Funding
                Tufts University School of Medicine was the sponsor. IBM Inc. and Pfizer Inc. funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Medicine and Health Sciences
                Medical Conditions
                Neurodegenerative Diseases
                Movement Disorders
                Parkinson Disease
                Medicine and Health Sciences
                Neurology
                Neurodegenerative Diseases
                Movement Disorders
                Parkinson Disease
                Biology and Life Sciences
                Physiology
                Biological Locomotion
                Walking
                Physical Sciences
                Physics
                Classical Mechanics
                Acceleration
                Biology and Life Sciences
                Anatomy
                Body Limbs
                Arms
                Wrist
                Medicine and Health Sciences
                Anatomy
                Body Limbs
                Arms
                Wrist
                Physical Sciences
                Physics
                Classical Mechanics
                Motion
                Velocity
                Biology and Life Sciences
                Anatomy
                Body Limbs
                Medicine and Health Sciences
                Anatomy
                Body Limbs
                Biology and Life Sciences
                Anatomy
                Musculoskeletal System
                Skeleton
                Sternum
                Medicine and Health Sciences
                Anatomy
                Musculoskeletal System
                Skeleton
                Sternum
                Biology and Life Sciences
                Physiology
                Biological Locomotion
                Gait Analysis
                Custom metadata
                The data underlying this study contains sensitive participant information and cannot be shared publicly according to the terms of informed consent provided by participants. Data access requests should be directed to the Head of Digital Data Science at Pfizer, David Caouette ( david.caouette@ 123456pfizer.com ).

                Uncategorized
                Uncategorized

                Comments

                Comment on this article